Do statins have a role in the promotion of postoperative wound healing in cardiac surgical patients?
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 24980602.
- Also identified by DOI 10.1016/j.athoracsur.2014.02.089.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cardiac surgical patients often have associated comorbidities that can impede normal wound healing; however, statin therapy has the potential to improve this process through augmentation of the normal inflammatory response. Outcomes included a 30% earlier rate of wound epithelialization and an 80% greater wound-breaking strength combined with faster wound healing rates (13.0 days vs 18.7 days, p<0.0001). Inhibition of farnesyl pyrophosphate may hold a key role in the mediation of such advantageous effects. This systematic review suggests that there is sufficient evidence to warrant completion of a human trial to assess the effects of statins on wound healing.
Medical subject headings
- Cardiac Surgical Procedures
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Wound Healing